🔗 Share this article

Treasury head Reeves has stated she is preparing "targeted action to tackle cost of living pressures" in the forthcoming financial statement.

In comments to media outlets, she emphasized that lowering inflation is a shared task of both the administration and the central bank.

The United Kingdom's price growth is expected to be the most elevated among the Group of Seven advanced economies this year and the following year.

Potential Utility Bill Interventions

Sources suggest the government could take action to reduce utility costs, for example by reducing the present 5% level of VAT applied on energy supplies.

Another possibility is to cut some of the regulatory levies presently included in bills.

Budgetary Constraints and Expert Expectations

The administration will receive the next draft from the independent fiscal watchdog, the OBR, on the start of the week, which will clarify how much space there is for these actions.

The expectation from most experts is that Reeves will have to announce tax rises or expenditure reductions in order to adhere to her self-imposed borrowing rules.

Earlier on Thursday, analysis suggested there was a twenty-two billion pound gap for the chancellor to resolve, which is at the more modest range of projections.

"It is a shared job between the central bank and the government to bear down further on some of the causes of inflation," Reeves informed reporters in Washington, at the annual meetings of the IMF and global financial institution.

Tax Pledges and International Concerns

While much of the attention has been on probable tax rises, the Treasury chief said the most recent information from the OBR had not altered her vow to election pledges not to increase rates on income tax, sales tax or social security contributions.

She blamed an "unpredictable world" with increasing geopolitical and commercial concerns for the Budget tax moves, probably to be targeted on those "most able to pay."

Global Economic Tensions

Referring to apprehensions about the United Kingdom's commercial links with China she said: "Our security interests always take priority."

Recent declaration by Chinese authorities to tighten trade restrictions on rare earths and other resources that are crucial for advanced tech manufacturing led US President the US President to propose an further 100% import tax on goods from China, increasing the risk of an full-scale commercial conflict between the two global powers.

The American finance chief described the Chinese decision "economic coercion" and "a global supply chain control attempt."

Asked about considering the US offer to join its conflict with the Asian nation, the Chancellor said she was "extremely troubled" by Chinese measures and urged the Beijing authorities "not to put up barriers and restrict access."

She said the decision was "harmful for the global economy and causes additional obstacles."

"It is my opinion there are areas where we must confront China, but there are also important prospects to trade with China's economy, including banking sector and other sectors of the economic system. We've got to get that balance correct."

The Treasury chief also affirmed she was cooperating with G7 counterparts "on our own critical minerals strategy, so that we are more independent."

NHS Drug Costs and Funding

Reeves also recognized that the cost the National Health Service spends on medicines could go up as a consequence of current discussions with the Trump administration and its drugs companies, in exchange for lower tariffs and funding.

A number of the world's largest drug companies have said in recent statements that they are either halting or canceling investments in the United Kingdom, with several blaming the low prices they are receiving.

Last month, the government science advisor said the price the NHS spends on drugs would must increase to halt firms and drug research funding leaving the United Kingdom.

The Chancellor stated to media: "It has been observed due to the payment system, that clinical trials, recent pharmaceuticals have not been provided in the United Kingdom in the extent that they are in other EU nations."

"We want to ensure that patients receiving care from the National Health Service are can access the finest life-saving drugs in the world. And so we are looking at all of that, and... looking to secure additional capital into Britain."